Abbott Laboratories Financial Ratios — ABT.SW Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	16.11	17.9	7.37	6.59	11.99	3.63	1.11	4.97	7.54	8.86	13.12	11.96	9.35	19.88	8.83
Return on Assets (%)	7.82	9.35	4.68	5.43	10.73	2.98	0.74	3.3	5.46	6.4	9.57	9.27	7.75	17.33	7.76
Return on Capital (%)	10.85	- -	5.59	5.69	10.04	3.18	0.91	4.25	6.28	7.1	10.25	9.66	8.03	- -	7.78
Return on Invested Capital (%)	3.59	- -	5.24	5.81	7.84	6.23	0.49	5.43	8.17	9.4	13.51	12.77	10.21	- -	9.56
Gross Margin (%)	53.21	53.29	53.23	54.47	57.13	56.39	54.7	58.45	58.53	56.65	56.97	56.15	55.18	55.41	56.42
EBITDA Margin (%)	21.83	21.74	19.6	20.48	21.26	21	16.74	22.66	23.65	25.09	27.77	26.64	24.24	23.94	25.2
Operating Margin (%)	7.61	7.14	10.85	12.84	14.05	14.51	5.71	11.94	14.21	15.48	19.56	19.16	16.15	16.27	18.17
Incremental Operating Margin (%)	34.68	11.41	127.35	78.98	169.62	35.49	-22.36	65.43	66.52	30.51	36.23	-10.9	53.16	18.85	51.64
Pretax Margin (%)	5.77	-1.15	10.38	12.44	15.6	6.78	8.15	9.4	12.78	14.36	19.06	19.03	16.61	16.72	19.1
Profit Margin (%)	22.09	31.3	13.1	11.28	21.68	6.71	1.74	7.74	11.56	12.99	16.42	15.88	14.27	31.95	14.72
Net Income to Common Margin (%)	22.09	31.3	13.1	11.28	21.68	6.71	1.74	7.74	11.56	12.99	16.42	15.88	14.27	31.95	14.72
Effective Tax Rate (%)	8.9	- -	2.6	31.65	18.13	24.77	84.18	18.76	9.57	10	13.88	16.53	14.12	- -	22.94
Dvd Payout Ratio (%)	260.92	1,343.04	44.37	77.98	55.37	144.78	523.8	84.58	61.57	57.26	45.28	47.73	62.14	28.62	63.09
Sustainable Growth Rate (%)	-25.93	-222.49	4.1	1.45	5.35	-1.63	-4.71	0.77	2.9	3.79	7.18	6.25	3.54	14.19	3.26

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	15,415	20,476	6,561	7,830	9,001	22,006	27,924	19,566	18,894	19,649	19,006	17,716	15,628	15,021	13,860
ST Debt	3,375	2,391	3,173	4,437	3,130	1,325	714	207	1,478	220	754	2,251	1,080	1,500	3,033
LT Debt	12,040	18,085	3,388	3,393	5,871	20,681	27,210	19,359	17,416	19,429	18,252	15,465	14,548	13,521	10,827
Total Debt/EBITDA	3.3	4.94	1.7	1.89	2.07	5.03	6.09	2.82	2.5	2.26	1.59	1.52	1.61	1.5	1.24
Net Debt/EBITDA	1.84	2.34	0.8	0.91	0.92	0.77	4.04	2.27	1.89	1.37	0.69	0.59	0.8	0.65	0.39
Total Debt/EBIT	9.46	15.06	3.08	3.01	3.14	7.27	17.85	5.36	4.17	3.67	2.26	2.12	2.41	2.2	1.72
Net Debt/EBIT	5.28	7.11	1.45	1.45	1.4	1.12	11.84	4.31	3.15	2.22	0.98	0.82	1.2	0.95	0.55
EBITDA to Interest Expense	13.02	12.94	26.57	27.65	26.62	10.16	5.07	8.39	11.26	15.9	22.44	20.84	15.26	17.97	22.66
EBITDA-CapEx/Interest Expense	8.86	7.33	18.67	20.47	19.81	7.56	3.82	6.7	8.82	11.92	18.91	17.66	11.8	14.02	18.25
EBIT to Interest Expense	4.54	4.25	14.71	17.33	17.59	7.02	1.73	4.42	6.76	9.81	15.81	14.99	10.17	12.21	16.33
Interest Expense	359	320	145	150	163	431	904	826	670	546	533	558	637	559	493
Common Equity/Total Assets	50.97	53.4	79.22	85.56	93.32	73.28	61.88	71.56	73.21	71.36	74.47	80.56	85.26	88.95	86.85
Long-Term Debt/Equity (%)	49.09	67.45	13.41	15.68	27.53	99.83	87.5	63.01	55.64	58.87	50.67	41.9	37.47	28.23	20.52
Long-Term Debt/Capital (%)	26.05	32.02	8.33	7.85	12.33	34.03	36.13	28.54	25.31	27.12	24.26	19.85	18.59	15.42	12.06
Long-Term Debt/Total Assets (%)	19.97	26.9	7.89	8.23	14.23	39.27	35.69	28.82	25.65	26.78	24.27	20.78	19.87	16.61	12.49
Total Debt/Equity (%)	62.85	76.37	25.97	36.18	42.21	106.22	89.79	63.69	60.36	59.54	52.76	48	40.25	31.36	26.26
Total Debt/Capital (%)	33.35	36.26	16.13	18.12	18.91	36.21	37.08	28.84	27.46	27.43	25.27	22.74	19.97	17.13	15.43
Total Debt/Total Assets (%)	25.57	30.45	15.27	19	21.82	41.78	36.62	29.13	27.83	27.08	25.28	23.8	21.35	18.45	15.98
Net Debt to Equity	35.07	36.08	12.21	17.41	18.76	16.34	59.54	51.18	45.62	36.08	22.9	18.67	20.05	13.59	8.35
Net Debt/Capital (%)	21.82	21.18	8.29	9.63	9.39	8.03	28.1	24.57	21.99	18.38	12.61	10.13	10.9	8.13	5.42
EBITDA	4,673	4,142	3,852	4,147	4,339	4,379	4,585	6,928	7,546	8,684	11,963	11,629	9,721	10,043	11,169
EBITDA-CapEx	3,182	2,347	2,707	3,070	3,229	3,258	3,450	5,534	5,908	6,507	10,078	9,852	7,519	7,836	8,998
Operating Income (Loss)	1,629	1,360	2,133	2,599	2,867	3,026	1,564	3,650	4,532	5,357	8,425	8,362	6,478	6,825	8,053

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.52	1.14	0.85	0.43	0.67	2.82	1.08	0.45	0.38	0.6	0.78	0.66	0.53	0.56	0.54
Current Ratio	1.54	2.36	2.02	1.3	1.54	4.02	2.26	1.62	1.44	1.72	1.85	1.63	1.64	1.67	1.58
Quick Ratio	1.15	1.85	1.43	0.96	1.25	3.58	1.85	1.2	1.04	1.3	1.46	1.23	1.16	1.23	1.18
CFO/Avg Current Liab	0.55	0.65	0.29	0.37	0.3	0.4	0.72	0.7	0.62	0.69	0.84	0.67	0.5	0.61	0.62
Common Equity/Total Assets	50.97	53.4	79.22	85.56	93.32	73.28	61.88	71.56	73.21	71.36	74.47	80.56	85.26	88.95	86.85
Long-Term Debt/Equity (%)	49.09	67.45	13.41	15.68	27.53	99.83	87.5	63.01	55.64	58.87	50.67	41.9	37.47	28.23	20.52
Long-Term Debt/Capital (%)	26.05	32.02	8.33	7.85	12.33	34.03	36.13	28.54	25.31	27.12	24.26	19.85	18.59	15.42	12.06
Long-Term Debt/Total Assets (%)	19.97	26.9	7.89	8.23	14.23	39.27	35.69	28.82	25.65	26.78	24.27	20.78	19.87	16.61	12.49
Total Debt/Equity (%)	62.85	76.37	25.97	36.18	42.21	106.22	89.79	63.69	60.36	59.54	52.76	48	40.25	31.36	26.26
Total Debt/Capital (%)	33.35	36.26	16.13	18.12	18.91	36.21	37.08	28.84	27.46	27.43	25.27	22.74	19.97	17.13	15.43
Total Debt/Total Assets (%)	25.57	30.45	15.27	19	21.82	41.78	36.62	29.13	27.83	27.08	25.28	23.8	21.35	18.45	15.98
CFO/Total Liabilities	25.09	23.04	18.79	18.78	14.89	10.03	12.34	17.28	16.77	19.98	26.89	25.53	21.12	25.54	28.18
CFO/CapEx	6.02	5.19	2.9	3.41	2.67	2.86	4.91	4.52	3.75	3.63	5.59	5.39	3.3	3.88	4.41
Altman's Z-Score	2.56	2.61	4.38	4.74	5	3.31	3.84	5.35	5.79	6.11	6.76	6.25	6.4	5.95	6.5

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	2.88	2.49	3.39	5.35	5.83	6.26	6.45	5.86	6.02	5.85	6.68	6.87	6.28	6.22	5.97
Days Sales Outstanding	126.75	146.55	107.69	68.25	62.64	58.34	56.62	62.26	60.68	62.43	54.66	53.12	58.16	58.69	61.15
Inventory Turnover	3.1	2.51	2.83	3.46	3.34	3.61	4.11	3.44	3.26	3.22	3.65	3.38	2.82	2.93	3.05
Days Inventory Outstanding	117.93	145.14	128.76	105.64	109.37	101	88.76	106.25	111.89	113.47	100.12	108.02	129.38	124.53	119.8
Accounts Payable Turnover	6.21	5.35	5.73	8.77	8.11	7.91	7.58	4.8	4.42	4.36	4.47	4.47	4.13	4.32	4.65
Accounts Payable Turnover Days	58.78	68.25	63.66	41.6	44.98	46.17	48.13	76.06	82.64	83.68	81.61	81.62	88.43	84.53	78.49
Cash Conversion Cycle	185.91	223.44	172.79	132.29	127.03	113.17	97.25	92.44	89.92	92.22	73.17	79.52	99.11	98.69	102.47
Inventory to Cash Days	8.82	1.41	-21.07	-37.39	-46.73	-42.66	-32.14	-43.99	-51.22	-51.04	-45.46	-54.9	-71.22	-65.84	-58.65
Inventories	3,284	3,793	2,693	2,643	2,599	2,434	3,601	3,796	4,316	5,012	5,157	6,173	6,570	6,194	6,488
Raw Materials	631	818	478	558	539	516	790	890	972	1,270	1,382	1,688	1,817	1,654	1,608
Work In Process	432	629	349	278	316	294	472	499	560	712	694	680	807	840	904
Finished Goods	2,221	2,346	1,866	1,807	1,744	1,624	2,339	2,407	2,784	3,030	3,081	3,805	3,946	3,700	3,976
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	38,733	51,497	54,798	70,202	74,451	56,784	93,981	121,161	157,198	206,901	227,764	189,804	191,546	179,038	217,036
- Cash & Cash Equivalents	6,813	10,802	3,475	4,063	5,001	18,620	9,407	3,844	3,860	6,838	9,799	9,882	6,896	7,616	8,522
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	86	92	96	113	115	179	201	198	213	219	222	219	224	237	641
+ Total Debt	15,415	20,476	6,561	7,830	9,001	22,006	27,924	19,566	18,894	19,649	19,006	17,716	15,628	15,021	13,860
Enterprise Value	46,136	56,891	53,357	73,685	77,442	60,194	112,496	136,839	172,165	219,621	236,743	197,569	200,119	186,329	222,598
Total Capital	46,225	56,474	40,684	43,200	47,607	60,777	75,309	67,836	68,807	71,640	75,226	77,901	78,275	87,672	89,809
Total Debt/Capital (%)	33.35	36.26	16.13	18.12	18.91	36.21	37.08	28.84	27.46	27.43	25.27	22.74	19.97	17.13	15.43
Total Debt / EV	0.33	0.36	0.12	0.11	0.12	0.37	0.25	0.14	0.11	0.09	0.08	0.09	0.08	0.08	0.06
EV/Sales	2.16	2.99	2.71	3.64	3.8	2.89	4.11	4.48	5.4	6.35	5.5	4.53	4.99	4.44	5.02
EV/EBITDA	9.87	13.74	13.85	17.77	17.85	13.75	24.54	19.75	22.82	25.29	19.79	16.99	20.59	18.55	19.93
EV/EBIT	28.32	41.83	25.02	28.35	27.01	19.89	71.93	37.49	37.99	41	28.1	23.63	30.89	27.3	27.64
EV/Cash Flow to Firm	4.96	6.34	15.4	19.51	24.99	17.07	19.69	19.63	25.54	26.17	21.54	19.66	25.63	19.36	22.38
EV/Free Cash Flow to Firm	4.28	5.29	11.57	15.18	18.4	12.95	16.43	16.36	20.54	20.78	18.38	16.71	19.99	15.75	18.37
Diluted Market Cap	38,733	51,998	55,715	71,085	76,136	57,175	94,272	122,153	158,848	208,627	230,981	192,667	193,194	180,723	218,586
Diluted Enterprise Value	47,421	61,764	58,897	74,965	80,251	60,740	112,990	138,073	174,095	221,657	240,410	200,720	202,150	188,365	224,565
EV per Share	29.38	36.08	34.47	48.86	52.59	40.87	64.52	77.94	97.68	123.99	134.2	113.69	115.4	107.6	128.18
TTM Sales	21,407	19,050	19,657	20,247	20,405	20,853	27,390	30,578	31,904	34,608	43,075	43,653	40,109	41,950	44,328
TTM EBITDA	4,673	4,142	3,852	4,147	4,339	4,379	4,585	6,928	7,546	8,684	11,963	11,629	9,721	10,043	11,169
TTM Operating Income	1,629	1,360	2,133	2,599	2,867	3,026	1,564	3,650	4,532	5,357	8,425	8,362	6,478	6,825	8,053
TTM Cash Flow to Firm	9,297	8,969	3,465	3,778	3,099	3,527	5,713	6,971	6,742	8,392	10,992	10,047	7,808	9,626	9,946
TTM Free Cash Flow to Firm	10,788	10,764	4,610	4,855	4,209	4,648	6,848	8,365	8,380	10,569	12,877	11,824	10,010	11,833	12,117

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	3.7	4.68	12.47	14.96	18.68	13.22	14.06	15.88	20.43	20.7	18.6	16.96	20.42	16.79	18.62
EV/EBIT	28.32	41.83	25.02	28.35	27.01	19.89	71.93	37.49	37.99	41	28.1	23.63	30.89	27.3	27.64
Enterprise Value	46,136	56,891	53,357	73,685	77,442	60,194	112,496	136,839	172,165	219,621	236,743	197,569	200,119	186,329	222,598
Low Price	21.73	24.87	32.06	34.58	42.16	35.52	38.24	51.63	68.14	72.31	96.29	104.19	97.66	100.99	101.92
EV/Sales	2.16	2.99	2.71	3.64	3.8	2.89	4.11	4.48	5.4	6.35	5.5	4.53	4.99	4.44	5.02
EV/EBITDA	9.87	13.74	13.85	17.77	17.85	13.75	24.54	19.75	22.82	25.29	19.79	16.99	20.59	18.55	19.93
Price/Earnings	8.19	8.64	21.27	30.74	16.83	40.56	197.03	51.17	42.64	46.03	32.21	27.38	33.47	13.36	33.27
Price/Earnings Average	8.34	8.15	21.49	26.61	15.73	44.27	173.74	47.09	38.74	38.01	28.42	28.07	31.79	13.73	32.1
Price/Earnings High	9.44	9.64	23.5	30.74	17.9	52.48	197.28	54.94	43.75	46.18	34.73	33.18	34.34	14.75	35.59
Price/Earnings Low	7.22	6.58	19.27	22.83	14.04	37.37	139.79	38.28	32.57	28.5	24.02	26.12	29.59	13.05	27.13
Price/Book Value	1.26	1.43	1.61	1.99	1.93	1.47	1.99	2.52	3.16	4	4.07	3.17	3.07	2.47	2.88
Price/Book Value Average	1.28	1.35	1.63	1.72	1.81	1.61	1.76	2.32	2.87	3.3	3.59	3.25	2.91	2.54	2.78
Price/Book Value High	1.45	1.6	1.78	1.99	2.06	1.9	1.99	2.71	3.25	4.01	4.39	3.84	3.15	2.73	3.08
Price/Book Value Low	1.11	1.09	1.46	1.48	1.61	1.36	1.41	1.89	2.42	2.47	3.03	3.02	2.71	2.42	2.35
Price/Tangible Book Value	-33.14	21.01	5.61	13.06	12.15	6.68	-6.53	-10.56	-17.63	-37.45	4,217.86	51.97	30.25	9.87	9.35
Price/Tangible Book Value Average	-33.73	19.82	5.67	11.31	11.36	7.3	-5.76	-9.72	-16.02	-30.93	3,721.28	53.29	28.73	10.14	9.02
Price/Tangible Book Value High	-38.19	23.44	6.2	13.06	12.92	8.65	-6.54	-11.34	-18.09	-37.57	4,547.54	62.99	31.03	10.9	10
Price/Tangible Book Value Low	-29.19	16	5.09	9.7	10.13	6.16	-4.63	-7.9	-13.47	-23.18	3,145.65	49.58	26.74	9.64	7.63
Price/Sales	1.81	2.7	2.79	3.47	3.65	2.72	3.43	3.96	4.93	5.98	5.29	4.35	4.78	4.27	4.9
Price/Sales Average	1.84	2.55	2.82	3	3.41	2.97	3.03	3.65	4.48	4.94	4.67	4.46	4.54	4.39	4.72
Price/Sales High	2.09	3.02	3.08	3.47	3.88	3.52	3.44	4.25	5.06	6	5.7	5.27	4.9	4.71	5.24
Price/Sales Low	1.59	2.06	2.53	2.58	3.04	2.51	2.43	2.96	3.76	3.7	3.94	4.15	4.22	4.17	3.99
Price/Cash Flow	4.32	5.53	16.49	19.1	25.1	17.73	16.87	19.23	25.62	26.19	21.62	19.81	26.38	20.92	22.69
Price/Cash Flow Average	4.4	5.22	16.66	16.54	23.46	19.35	14.88	17.7	23.28	21.63	19.08	20.31	25.06	21.5	21.89
Price/Cash Flow High	4.98	6.17	18.21	19.1	26.69	22.94	16.89	20.65	26.29	26.27	23.31	24.01	27.07	23.1	24.27
Price/Cash Flow Low	3.8	4.21	14.93	14.19	20.93	16.34	11.97	14.39	19.57	16.21	16.13	18.9	23.32	20.43	18.5
Price/Free Cash Flow Average	3.77	4.42	12.6	12.95	17.46	14.43	12.4	14.61	18.57	17.1	16.41	17.39	19.39	17.26	17.97
Price/Free Cash Flow High	4.27	5.22	13.77	14.96	19.86	17.11	14.08	17.05	20.97	20.77	20.05	20.56	20.95	18.54	19.92
Price/Free Cash Flow Low	3.26	3.56	11.29	11.11	15.58	12.18	9.98	11.88	15.61	12.82	13.87	16.18	18.05	16.4	15.19
EV/Sales Average	2.25	3.06	2.98	3.19	3.61	3.14	3.71	4.17	4.96	5.31	4.88	4.64	4.76	4.57	4.86
EV/Sales High	2.49	3.53	3.24	3.66	4.08	3.69	4.12	4.78	5.53	6.37	5.92	5.45	5.12	4.9	5.37
EV/Sales Low	2	2.57	2.69	2.77	3.24	2.68	3.12	3.48	4.24	4.08	4.16	4.33	4.45	4.35	4.13
EV/EBITDA Average	10.3	14.09	15.2	15.59	16.98	14.97	22.16	18.39	20.95	21.18	17.59	17.43	19.64	19.08	19.28
EV/EBITDA High	11.41	16.23	16.54	17.86	19.2	17.59	24.61	21.08	23.4	25.4	21.32	20.47	21.14	20.45	21.32
EV/EBITDA Low	9.16	11.82	13.71	13.51	15.26	12.76	18.63	15.38	17.94	16.25	14.99	16.26	18.34	18.17	16.38
EV/EBIT Average	29.54	42.91	27.45	24.88	25.7	21.66	64.96	34.91	34.88	34.33	24.97	24.24	29.47	28.08	26.75
EV/EBIT High	32.74	49.43	29.87	28.5	29.05	25.46	72.13	40	38.96	41.18	30.27	28.47	31.72	30.09	29.57
EV/EBIT Low	26.28	36.01	24.76	21.56	23.09	18.47	54.6	29.2	29.86	26.34	21.28	22.62	27.52	26.74	22.72
Last Price	24.66	32.66	35.4	46.55	50.56	38.55	53.9	69.01	89.19	116.81	129.11	109.22	110.46	103.39	124.98
High Price	28.43	36.44	39.1	46.55	53.76	49.88	53.97	74.1	91.53	117.19	139.2	132.37	113.34	114.18	133.7
Enterprise Value Average	48,113	58,354	58,551	64,661	73,692	65,550	101,593	127,422	158,096	183,891	210,378	202,679	190,885	191,670	215,379
Enterprise Value High	53,333	67,227	63,718	74,082	83,288	77,032	112,818	146,015	176,565	220,596	254,996	238,077	205,498	205,371	238,166
Enterprise Value Low	42,807	48,977	52,819	56,022	66,198	55,889	85,398	106,563	135,346	141,116	179,294	189,114	178,298	182,524	182,968

Shares Outstanding	1,570	1,577	1,548	1,508	1,473	1,473	1,744	1,756	1,763	1,771	1,764	1,738	1,734	1,732	1,737
Diluted Weighted Avg Shares	1,570	1,592	1,574	1,527	1,506	1,483	1,749	1,770	1,781	1,786	1,789	1,764	1,749	1,748	1,749
Basic Weighted Avg Shares	1,570	1,577	1,548	1,508	1,473	1,473	1,744	1,756	1,763	1,771	1,764	1,738	1,734	1,732	1,737
Revenue per Share	13.63	12.08	12.7	13.43	13.86	14.16	15.71	17.42	18.1	19.54	24.42	25.12	23.13	24.22	25.53
EBITDA per Share	2.98	2.63	2.49	2.75	2.95	2.97	2.63	3.95	4.28	4.9	6.78	6.69	5.61	5.8	6.43
Operating Income per Share	1.04	0.86	1.38	1.72	1.95	2.05	0.9	2.08	2.57	3.02	4.78	4.81	3.74	3.94	4.64
Basic EPS, GAAP	3.01	3.78	1.66	1.51	3	0.95	0.27	1.35	2.09	2.54	4.01	3.99	3.3	7.74	3.76
Basic EPS from Cont Ops	0.72	0.15	1.28	1.14	1.77	0.72	0.2	1.33	2.09	2.52	4.01	3.99	3.3	7.74	3.76
Diluted EPS, GAAP	3.01	3.75	1.64	1.5	2.94	0.94	0.27	1.34	2.07	2.52	3.95	3.93	3.27	7.67	3.73
Diluted EPS from Cont Ops	0.72	0.15	1.26	1.13	1.73	0.72	0.2	1.32	2.07	2.5	3.95	3.93	3.27	7.67	3.73
Dividend per Share	1.87	2.02	0.57	0.89	0.98	1.04	1.06	1.12	1.29	1.45	1.82	1.9	2.05	2.22	2.37
Cash Flow per Share	5.71	5.91	2.15	2.44	2.01	2.17	3.19	3.59	3.48	4.46	5.97	5.51	4.19	4.94	5.51
Free Cash Flow per Basic Share	4.76	4.77	1.41	1.72	1.26	1.41	2.54	2.79	2.55	3.23	4.9	4.49	2.92	3.67	4.26
Cash & Equivalents per Share	5.16	9.62	5.23	2.96	4.16	12.75	5.51	2.33	2.35	4.04	5.81	5.85	4.2	4.6	5.15
Book Value per Share	19.57	22.77	21.98	23.38	26.14	26.2	27.06	27.38	28.2	29.23	31.74	34.51	36	41.82	43.37
Tangible Book Value per Share	-0.74	1.55	6.3	3.56	4.16	5.77	-8.26	-6.54	-5.06	-3.12	0.03	2.1	3.65	10.48	13.37

Abbott Laboratories

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)